Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for Primary Sjogren's Disease
28 locations incl. Chandler
Sponsor: Vor Biopharma
Sex: All·Age: 18 - 75
Code: NCT07404865·Phase 3·Recruiting·Listed Feb 2026
Clinical research site in Flagstaff, Arizona · 399 S MALPAIS LN STE 108, FLAGSTAFF, AZ 86001-6299 · (480) 443-8470 · Website
Part of Arizona Arthritis & Rheumatology Associates
As of July 2026, 1 paid clinical trial is recruiting at Arizona Arthritis & Rheumatology Associates P.C. in Flagstaff, Arizona. Active studies at this site focus on Primary Sjogren's Disease alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Flagstaff, AZ · Arizona clinical trials